Company profile for Citius Oncology

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Citius Oncology is a biotechnology company dedicated to developing innovative cancer therapies designed to enhance patient care and outcomes. We focus on discovering and advancing next-generation oncology treatments that address unmet medical needs. By leveraging cutting-edge research and technology, Citius Oncology aims to deliver safe, effective, and targeted solutions to combat various types of cancer. Our mission is to tra...
Citius Oncology is a biotechnology company dedicated to developing innovative cancer therapies designed to enhance patient care and outcomes. We focus on discovering and advancing next-generation oncology treatments that address unmet medical needs. By leveraging cutting-edge research and technology, Citius Oncology aims to deliver safe, effective, and targeted solutions to combat various types of cancer. Our mission is to transform cancer treatment and improve the lives of patients worldwide through innovative science and a commitment to excellence.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
11 Commerce Drive, First Floor Cranford, NJ 07016
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/citius-oncology-announces-us-commercial-launch-of-lymphir-a-novel-cancer-immunotherapy-for-cutaneous-t-cell-lymphoma-ctcl-302627320.html

PR NEWSWIRE
01 Dec 2025

https://www.prnewswire.com/news-releases/citius-oncology-to-exhibit-at-the-67th-american-society-of-hematology-ash-annual-meeting-302625063.html

PR NEWSWIRE
25 Nov 2025

https://www.prnewswire.com/news-releases/citius-oncology-to-advance-commercial-launch-of-lymphir-with-verix-ai-integration-302622336.html

PR NEWSWIRE BIO
21 Nov 2025

https://www.prnewswire.com/news-releases/citius-oncology-signs-us-distribution-agreement-with-mckesson-to-support-lymphir-commercial-launch-302588638.html

PR NEWSWIRE
20 Oct 2025

https://www.prnewswire.com/news-releases/citius-pharmaceuticals-and-citius-oncology-to-participate-in-upcoming-october-2025-conferences-302586084.html

PR NEWSWIRE
17 Oct 2025

https://www.prnewswire.com/news-releases/citius-oncology-signs-exclusive-commercialization-agreement-with-eversana-to-support-planned-q4-2025-launch-of-lymphir-302585992.html

PR NEWSWIRE
16 Oct 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty